Therefore, on the basis of the above-mentioned analysis, it can be preliminarily shown that the FAK/ERK/S100A4 signal pathway may become the vital medium for JWH133 to exert the anti-fibrosis role in mouse pulmonary fibrosis. Here, MAPK1 is linked to pulmonary fibrosis.